Shelley B Thunen
CIK 1297491 · See remarks · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$335.0K
Companies
7
Total Filings
45
Lifetime Open-Market Net
-$8.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AEON | Director | 258,705 | $0.28 | $71.7K | $0 | 3 | 2026-06-22 |
| LENZ | Director | — | $5.31 | — | $0 | 2 | 2026-06-15 |
| RXST | See remarks | 38,354 | $6.87 | $263.3K | -$8.54M | 16 | 2025-04-15 |
| AEON Biopharma, Inc. (AEON.WS) Delisted | Director | — | $1.05 | — | $0 | 2 | 2024-03-21 |
| Venus Concept Inc. (HAIR) Delisted | Director | — | — | — | $0 | 1 | 2018-06-15 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Chief Financial Officer | 1,714 | — | — | $0 | 5 | 2015-10-21 |
| INTRALASE CORP (ILSE) Delisted | EVP & CFO | 32,548 | — | — | $0 | 2 | 2007-04-02 |
Recent Filings · Page 3 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-06 | RXST | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | RXST | Mixed | — | -$407.7K | EDGAR |
| 2024-03-01 | RXST | Notice (144) | −10,000 | -$563.7K | EDGAR |
| 2024-02-07 | RXST | Mixed | +6,900 | -$779.0K | EDGAR |
| 2024-02-06 | RXST | Notice (144) | −15,875 | -$737.6K | EDGAR |
| 2024-02-05 | RXST | Notice (144) | −25,000 | -$1.18M | EDGAR |
| 2024-01-29 | RXST | Mixed | +4,500 | -$998.1K | EDGAR |
| 2024-01-26 | RXST | Notice (144) | −31,772 | -$1.49M | EDGAR |
| 2024-01-03 | RXST | Mixed | — | -$236.4K | EDGAR |
| 2024-01-02 | RXST | Notice (144) | −10,000 | -$392.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.